Attività di ricerca
Ultime pubblicazioni:
-
Di Giacomo, A.M., Subudhi, S., Vos, W., Andreatta, M., Carmona, S., Mctavish, W., et al. (2025). Perspectives on the role of “-Omics” in predicting response to immunotherapy. EUROPEAN JOURNAL OF CANCER, 220 [10.1016/j.ejca.2025.115393]. - dettaglio
-
Lofiego, M.F., Piazzini, F., Caruso, F.P., Marzani, F., Solmonese, L., Bello, E., et al. (2024). Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches. JOURNAL OF TRANSLATIONAL MEDICINE, 22(1) [10.1186/s12967-024-05040-x]. - dettaglio
-
Valente, M., Colucci, M., Vegni, V., Croce, V., Bellan, C., Rossi, G., et al. (2024). A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis. ONCOTARGETS AND THERAPY, 17, 673-681 [10.2147/OTT.S470892]. - dettaglio
-
Necchi, A., Pouessel, D., Leibowitz, R., Gupta, S., Fléchon, A., García-Donas, J., et al. (2024). Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201. ANNALS OF ONCOLOGY, 35(2), 200-210 [10.1016/j.annonc.2023.10.794]. - dettaglio
-
Roccuzzo, G., Gherardi, E., Maio, M., Malagoli, P., Marzano, A.V., Parodi, A., et al. (2024). Immunotherapy in cutaneous melanoma and biologics in psoriatic disease: similarities and differences from a clinical multidisciplinary perspective. EXPERT OPINION ON BIOLOGICAL THERAPY, 24(3), 125-131 [10.1080/14712598.2024.2326168]. - dettaglio